CTRI/2011/07/001899已完成2 期
Evaluation of Pantoprazole (PPI) on Glucose - Insulin homeostasis in patients with Type-2 Diabetes Mellitus: A Randomized Double Blind Placebo Controlled (Proof of Concept) Study
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- PGIMER
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •?Type-2 DM 5 years duration
- •?On oral antidiabetic therapy ( Metformin±Sulfonylurea)
- •?No change in anti-diabetic treatment for the last one month
- •?HbA1c 8.5%
- •?Fasting plasma glucose not exceeding 300mg/dL
- •?Patients willing to provide written informed consent
排除标准
- •?Diabetes other than type 2 diabetes mellitus
- •?Evidence of renal disease (S. creatinine 1.5mg/ml)
- •? Evidence of liver disease (AST/ALT 3 times normal)
- •? Pregnant and lactating mothers and women intending pregnancy
- •?Participation in any other clinical trial with in the last 30 days
- •?History of any hemoglobinopathy that may affect determination of Glycosylated Hemoglobin
- •?Treatment with oral anti-diabetic agents (other than metformin or SU) during the 12 weeks before baseline visit
- •?History of intolerance or hypersensitivity to sulfonylurea or metformin or PPI
研究者
相似试验
已完成
不适用
Effects of Pantoprazole on serum glucose level in type two diabetic patientsType 2 diabetes.Endocrine, nutritional and metabolic diseasesIRCT2013070713612N2Research deputy of Tabriz University of Medical Sciences40
Unknown
3 期
Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 DiabetesDiabetes MellitusNCT02345239Dr. Waheed Rehman14
已完成
2 期
Pantoprazole on Insulin Secretion in DiabetesType 2 DiabetesNCT01541735Coordinación de Investigación en Salud, Mexico14
招募中
不适用
Effects of Glucose-Insulin-PotassiumCondition 1: Hypotension, impaired hemodynamic parameters. Condition 2: Impaired cardiac indexes (heart failure).Unspecified systolic (congestive) heart failureI50.20HypotensionIRCT20220730055585N1Tehran University of Medical Sciences50
尚未招募
2 期
A study on the effects on plasma insulin and glucose after a single meal replacement (InsuVital) with or without added Leucine in patients with T2DMdiabetesglucose intolerance10018424NL-OMON31143DSM Food Specialties36